Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallop…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer [NA]
Clinical trial update for hyperthermic intraperitoneal chemotherapy using carboplatin in first recurrence ovarian cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels [Phase 2]
Phase 2 trial evaluating the efficacy of Å6 in ovarian cancer patients who have completed first-line chemotherapy and show rising CA-125; th…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without paclitaxel and carboplatin for recurrent ovarian, fallopian tube, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Phase 2]
The Phase 2 study evaluating the combination of Iressa (gefitinib) and Anastrozole (Arimidex) in ovarian, peritoneal, and tubal carcinomas h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.